RPS Pharma Scene #26 - Clinical Trials and Regulatory Affairs
With Rebecca Stanbrook
In this 26th episode of the Royal Pharmaceutical Society Pharma Scene podcast, we're joined by Rebecca Stanbrook, Executive Director, Development and Regulatory Policy at Novartis.
She talks to our regular host, Ciara Duffy, about clinical trials and regulatory affairs, and they discuss some of the entry roads into the industry.
Rebecca sits on the RPS' Industrial Pharmacy Advisory Group, and has had a fascinating career in pharmacy; so, if you're thinking about a career in clinical trials and regulation then you'll find this discussion very interesting!
Download a transcript of this podcast
BPharm (Hons), MRPharmS, FFRPS, DipRQA, MRQA
Rebecca Stanbrook has worked in the pharmaceutical industry, as a regulator at MHRA and at various pharmaceutical companies for over 30 years. Her main areas of interest are clinical trials and pharmacovigilance. She is a pharmacist by profession and holds a Diploma in Research Quality Assurance.
Rebecca is thrilled to be a member of the ICH E6 (R3) Expert Working Group as the EFPIA Topic Lead.
Currently Rebecca works as Executive Director, Regulatory and Development Policy in the Regulatory Affairs Group of Novartis Pharma AG. She is based in Basel - find out more at LinkedIn